共 50 条
- [26] Febuxostat or Allopurinol in Patients with Gout Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout and Cardiovascular Morbidities (CARES) INTERNIST, 2020, 61 (05): : 530 - 532
- [27] Assessment of cardiovascular risk profile based on measurement of tophus volume in patients with gout Clinical Rheumatology, 2018, 37 : 1351 - 1358
- [30] The Effects of Liver Disease on Cardiovascular Mortality Among Patients With Cardiovascular Disease AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S1602 - S1602